Detection of Clonal Rearrangements in Multiple Myeloma Samples Using LymphoTrack Assays

被引：0
|
作者：
Huang, Y. [1 ,2 ]
Jacobsen, A. [1 ,2 ]
Panganiban, J. [1 ]
Vigil, E. [1 ]
Hutt, K. [1 ]
Heilman, J. [1 ]
Blankfard, M. [1 ]
Stenzel, T. [1 ]
Rustad, E. H. [2 ]
Hultcrantz, M. [2 ]
Landgren, O. [2 ]
Miller, J. E. [1 ]
机构：
[1] Invivoscribe, San Diego, CA USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2018年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
H045
引用
收藏
页码：930 / 930
页数：1
相关论文
共 50 条
  • [21] Clonal competition with alternating dominance in multiple myeloma
    Keats, Jonathan J.
    Chesi, Marta
    Egan, Jan B.
    Garbitt, Victoria M.
    Palmer, Stephen E.
    Braggio, Esteban
    Van Wier, Scott
    Blackburn, Patrick R.
    Baker, Angela S.
    Dispenzieri, Angela
    Kumar, Shaji
    Rajkumar, S. Vincent
    Carpten, John D.
    Barrett, Michael
    Fonseca, Rafael
    Stewart, A. Keith
    Bergsagel, P. Leif
    BLOOD, 2012, 120 (05) : 1067 - 1076
  • [22] In Vivo Analysis of Clonal Evolution of Multiple Myeloma
    Mishima, Yuji
    Shi, Jiantao
    Moschetta, Michele
    Shen, Yujia
    Manier, Salomon
    Roccaro, Aldo M.
    Mercier, Francois
    Takagi, Satoshi
    Kawano, Yawara
    Tsukamoto, Shokichi
    Sahin, Ilyas
    Sacco, Antonio
    Hatake, Kiyohiko
    Michor, Franziska
    Scadden, David T.
    Ghobrial, Irene M.
    BLOOD, 2016, 128 (22)
  • [23] The role of clonal evolution in smoldering multiple myeloma
    Bhatnagar, Vishal
    Badros, Ashraf
    LEUKEMIA & LYMPHOMA, 2014, 55 (02) : 464 - 466
  • [24] Identification of Clonal Igh Gene Rearrangements By High-Throughput Sequencing of Cell Free DNA in Multiple Myeloma Patients
    Gimondi, Silvia
    Cavane, Alessandra
    Vendramin, Antonio
    Giulia, Biancon
    Bermema, Anisa
    Montefusco, Vittorio
    Corradini, Paolo
    Carniti, Cristiana
    BLOOD, 2015, 126 (23)
  • [25] Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma
    Bianchi, Giada
    Ghobrial, Irene M.
    CURRENT CANCER THERAPY REVIEWS, 2014, 10 (02) : 70 - 79
  • [26] Uncovering Clonal and Subclonal Druggable Targets in Multiple Myeloma Using Omic Data
    Scott, Adam David
    Yellapantula, Venkata D.
    Yoon, Christopher J.
    Wendl, Michael
    Tomasson, Michael H.
    Fiala, Mark A.
    DiPersio, John F.
    Vij, Ravi
    Ding, Li
    BLOOD, 2016, 128 (22)
  • [27] DETECTION OF CLONALITY IN CLINICAL SPECIMENS FROM SUSPECTED B-CELL MALIGNANCIES USING COMPREHENSIVE IGH LYMPHOTRACK® MISEQ® AND PGM® ASSAYS
    Huang, Y.
    Hutt, K.
    Panganiban, J.
    Jacobsen, A.
    Wong, N.
    Duong, D.
    Bob, R.
    Pileri, S. A.
    Bernard, L.
    Gerbino, E.
    Stenzel, T.
    Miller, J. E.
    HAEMATOLOGICA, 2017, 102 : 349 - 350
  • [28] Dual-color immunohistochemistry assays for measuring Aiolos and Ikaros proteins in multiple myeloma patient samples
    Ren, Yan
    Wang, Maria
    Couto, Suzana
    Hansel, Donna
    Gandhi, Anita K.
    Hagner, Patrick
    Thakurta, Anjan
    Chopra, Rajesh
    Breider, Mike
    CANCER RESEARCH, 2015, 75
  • [29] Analysis of intratumor heterogeneity in multiple myeloma using methylcellulose clonogenic assays.
    Arendt, BK
    Fonseca, R
    Ahmann, G
    Jelinek, DF
    BLOOD, 2004, 104 (11) : 645A - 646A
  • [30] IMMUNOGLOBULIN GENE REARRANGEMENTS IN HUMAN MULTIPLE-MYELOMA
    ZACCARIA, A
    TASSINARI, A
    SAGLIO, G
    GUERRASIO, A
    TURA, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (03) : 425 - 425
12345